FOLFOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer patients with unresectable liver metastases

por Antoniotti, Carlotta, Vetere, Guglielmo, Cremolini, Chiara
Publicado 2022

Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response

por Hijazi, Assia, Antoniotti, Carlotta, Cremolini, Chiara, Galon, Jérôme
Publicado 2023

The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer

por Antoniotti, Carlotta, Ongaro, Elena, Falcone, Alfredo, Cremolini, Chiara
Publicado 2018

Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability

por Borelli, Beatrice, Antoniotti, Carlotta, Carullo, Martina, Germani, Marco Maria, Conca, Veronica, Masi, Gianluca
Publicado 2022

KRAS and BRAF genotyping of synchronous colorectal carcinomas

por GIANNINI, RICCARDO, LUPI, CRISTIANA, LOUPAKIS, FOTIOS, SERVADIO, ADELE, CREMOLINI, CHIARA, SENSI, ELISA, CHIARUGI, MASSIMO, ANTONIOTTI, CARLOTTA, BASOLO, FULVIO, FALCONE, ALFREDO, FONTANINI, GABRIELLA
Publicado 2014

The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab

por Demurtas, Laura, Puzzoni, Marco, Giampieri, Riccardo, Ziranu, Pina, Pusceddu, Valeria, Mandolesi, Alessandra, Cremolini, Chiara, Masi, Gianluca, Gelsomino, Fabio, Antoniotti, Carlotta, Loretelli, Cristian, Meriggi, Fausto, Zaniboni, Alberto, Falcone, Alfredo, Cascinu, Stefano, Scartozzi, Mario
Publicado 2017

Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis

por Cremolini, Chiara, Antoniotti, Carlotta, Pietrantonio, Filippo, Berenato, Rosa, Tampellini, Marco, Baratelli, Chiara, Salvatore, Lisa, Marmorino, Federica, Borelli, Beatrice, Nichetti, Federico, Bironzo, Paolo, Sonetto, Cristina, Bartolomeo, Maria Di, de Braud, Filippo, Loupakis, Fotios, Falcone, Alfredo, Maio, Massimo Di
Publicado 2017

Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies

por Fanotto, Valentina, Rossini, Daniele, Casagrande, Mariaelena, Bergamo, Francesca, Spagnoletti, Andrea, Santini, Daniele, Antoniotti, Carlotta, Cupini, Samanta, Daniel, Francesca, Nasca, Vincenzo, Vetere, Guglielmo, Zaniboni, Alberto, Borelli, Beatrice, Carullo, Martina, Conca, Veronica, Passardi, Alessandro, Tamburini, Emiliano, Masi, Gianluca, Pella, Nicoletta, Cremolini, Chiara
Publicado 2023

Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study

por Cremolini, Chiara, Pietrantonio, Filippo, Tomasello, Gianluca, Dadduzio, Vincenzo, Moretto, Roberto, Morano, Federica, Schirripa, Marta, Antoniotti, Carlotta, Fucà, Giovanni, Bergamo, Francesca, Rossini, Daniele, Nichetti, Federico, Ziampiri, Stamatia, Ghidini, Michele, Marmorino, Federica, Prisciandaro, Michele, Falcone, Alfredo, De Braud, Filippo, Loupakis, Fotios, Lonardi, Sara
Publicado 2017

Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study

por Moretto, Roberto, Rossini, Daniele, Catteau, Aurélie, Antoniotti, Carlotta, Giordano, Mirella, Boccaccino, Alessandra, Ugolini, Clara, Proietti, Agnese, Conca, Veronica, Kassambara, Alboukadel, Pietrantonio, Filippo, Salvatore, Lisa, Lonardi, Sara, Tamberi, Stefano, Tamburini, Emiliano, Poma, Anello Marcello, Fieschi, Jacques, Fontanini, Gabriella, Masi, Gianluca, Galon, Jérôme, Cremolini, Chiara
Publicado 2023

Prospective Validation of Candidate SNPs of VEGF/VEGFR Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Plus Bevacizumab

por Loupakis, Fotios, Cremolini, Chiara, Yang, Dongyun, Salvatore, Lisa, Zhang, Wu, Wakatsuki, Takeru, Bohanes, Pierre, Schirripa, Marta, Benhaim, Leonor, Lonardi, Sara, Antoniotti, Carlotta, Aprile, Giuseppe, Graziano, Francesco, Ruzzo, Annamaria, Lucchesi, Sara, Ronzoni, Monica, De Vita, Ferdinando, Tonini, Giuseppe, Falcone, Alfredo, Lenz, Heinz-Josef
Publicado 2013

Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO

por Rossini, Daniele, Lonardi, Sara, Antoniotti, Carlotta, Santini, Daniele, Tomasello, Gianluca, Ermacora, Paola, Germani, Marco Maria, Bergamo, Francesca, Ricci, Vincenzo, Caponnetto, Salvatore, Moretto, Roberto, Zaniboni, Alberto, Pietrantonio, Filippo, Buonadonna, Angela, Ritorto, Giuliana, Masi, Gianluca, Latiano, Tiziana Pia, Rapisardi, Stefania, Falcone, Alfredo, Cremolini, Chiara
Publicado 2020

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

por Cremolini, Chiara, Marmorino, Federica, Loupakis, Fotios, Masi, Gianluca, Antoniotti, Carlotta, Salvatore, Lisa, Schirripa, Marta, Boni, Luca, Zagonel, Vittorina, Lonardi, Sara, Aprile, Giuseppe, Tamburini, Emiliano, Ricci, Vincenzo, Ronzoni, Monica, Pietrantonio, Filippo, Valsuani, Chiara, Tomasello, Gianluca, Passardi, Alessandro, Allegrini, Giacomo, Di Donato, Samantha, Santini, Daniele, Falcone, Alfredo
Publicado 2017

NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients

por Schirripa, Marta, Zhang, Wu, Yang, Dongyun, Cao, Shu, Okazaki, Satoshi, Loupakis, Fotios, Berger, Martin D., Ning, Yan, Miyamoto, Yuji, Suenaga, Mitsukuni, Alberti, Giulia, West, Jordan D., Lonardi, Sara, Khoukaz, Taline, Bergamo, Francesca, Battaglin, Francesca, Antoniotti, Carlotta, Falcone, Alfredo, Stintzing, Sebastian, Heinemann, Volker, Lenz, Heinz-Josef
Publicado 2018

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorec...

por Antoniotti, Carlotta, Borelli, Beatrice, Rossini, Daniele, Pietrantonio, Filippo, Morano, Federica, Salvatore, Lisa, Lonardi, Sara, Marmorino, Federica, Tamberi, Stefano, Corallo, Salvatore, Tortora, Giampaolo, Bergamo, Francesca, Brunella, Di Stefano, Boccaccino, Alessandra, Grassi, Elisa, Racca, Patrizia, Tamburini, Emiliano, Aprile, Giuseppe, Moretto, Roberto, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara
Publicado 2020

DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer

por Cremolini, Chiara, Del Re, Marzia, Antoniotti, Carlotta, Lonardi, Sara, Bergamo, Francesca, Loupakis, Fotios, Borelli, Beatrice, Marmorino, Federica, Citi, Valentina, Cortesi, Enrico, Moretto, Roberto, Ronzoni, Monica, Tomasello, Gianluca, Zaniboni, Alberto, Racca, Patrizia, Buonadonna, Angela, Allegrini, Giacomo, Ricci, Vincenzo, Di Donato, Samantha, Zagonel, Vittorina, Boni, Luca, Falcone, Alfredo, Danesi, Romano
Publicado 2017

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

por Fucà, Giovanni, Guarini, Vincenzo, Antoniotti, Carlotta, Morano, Federica, Moretto, Roberto, Corallo, Salvatore, Marmorino, Federica, Lonardi, Sara, Rimassa, Lorenza, Sartore-Bianchi, Andrea, Borelli, Beatrice, Tampellini, Marco, Bustreo, Sara, Claravezza, Matteo, Boccaccino, Alessandra, Murialdo, Roberto, Zaniboni, Alberto, Tomasello, Gianluca, Loupakis, Fotios, Adamo, Vincenzo, Tonini, Giuseppe, Cortesi, Enrico, de Braud, Filippo, Cremolini, Chiara, Pietrantonio, Filippo
Publicado 2020

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF...

por Rossini, Daniele, Antoniotti, Carlotta, Lonardi, Sara, Pietrantonio, Filippo, Moretto, Roberto, Antonuzzo, Lorenzo, Boccaccino, Alessandra, Morano, Federica, Brugia, Marco, Pozzo, Carmelo, Marmorino, Federica, Bergamo, Francesca, Tamburini, Emiliano, Passardi, Alessandro, Randon, Giovanni, Murgioni, Sabina, Borelli, Beatrice, Buonadonna, Angela, Giordano, Mirella, Fontanini, Gabriella, Conca, Veronica, Formica, Vincenzo, Aglietta, Massimo, Bordonaro, Roberto, Aprile, Giuseppe, Masi, Gianluca, Boni, Luca, Cremolini, Chiara
Publicado 2022

TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-t...

por Borelli, Beatrice, Moretto, Roberto, Lonardi, Sara, Bonetti, Andrea, Antoniotti, Carlotta, Pietrantonio, Filippo, Masi, Gianluca, Burgio, Valentina, Marmorino, Federica, Salvatore, Lisa, Rossini, Daniele, Zaniboni, Alberto, Zucchelli, Gemma, Martignetti, Angelo, Di Battista, Monica, Pella, Nicoletta, Passardi, Alessandro, Boccaccino, Alessandra, Leone, Francesco, Colombo, Camilla, Granetto, Cristina, Vannini, Francesca, Marsico, Valentina Angela, Martinelli, Erika, Antonuzzo, Lorenzo, Vitello, Stefano, Delliponti, Laura, Boni, Luca, Cremolini, Chiara, Falcone, Alfredo
Publicado 2018

Vessel-Guided Mesohepatectomy for Liver Partition and Staged Major Parenchyma-Sparing Hepatectomies with Super-Selective Portal Vein Embolization or Enhanced ALPPS to Achieve R0 Re...

por Urbani, Lucio, Roffi, Nicolò, Moretto, Roberto, Signori, Stefano, Balestri, Riccardo, Rossi, Elisabetta, Colombatto, Piero, Licitra, Gabriella, Leoni, Chiara, Martinelli, Rita, Meiattini, Daniele Anacleto, Bonistalli, Emidio, Borelli, Beatrice, Antoniotti, Carlotta, Masi, Gianluca, Rossini, Daniele, Boraschi, Piero, Donati, Francescamaria, Della Pina, Maria Clotilde, Lunardi, Alessandro, Daviddi, Francesco, Crocetti, Laura, Tonerini, Michele, Gigoni, Roberto, Quilici, Francesca, Gaeta, Raffaele, Turco, Francesca, Paolicchi, Adriana, Volterrani, Duccio, Nardini, Vincenzo, Buccianti, Piero, Forfori, Francesco, Puccini, Marco, Cremolini, Chiara
Publicado 2023